For instance, the mRNA expression of PTPN12 was up-regulated in ten types of cancer, and connected with drug sensitivity to 9 anti-cancer drugs (e.g., Trametinib, Rs = -0.38, FDR< 3.7 × 10-20) and linked to drug resistance to 33 anti-cancer drugs (e.g., THZ-2-102-1, Rs = 0.32, FDR< 7.1 × 10-23). This evidence concerns the gene PTPN12 and cancer.